Challenges in Anti-Viral Drug Therapy

Lack of interest from pharmaceutical companies in antiviral drug development

Limitation of standardized in vitro cellular systems and in vivo animal models for studying viruses (correct)

Lack of funding for anti-viral drug research

Difficulty in synthesizing antiviral compounds

Government regulations make it difficult to conduct antiviral drug trials

There is a lack of skilled scientists working on antiviral drug development

Pharmaceutical companies are not interested in investing in antiviral drug research

Viruses have a great ability to develop high rates of resistance to most antiviral drugs (correct)

They are difficult to administer to patients

They are not effective against newly identified viruses

They have severe side effects on patients

They inhibit only active replicating viruses, but do not eliminate non-replicating or latent viruses (correct)

<p>Viruses are intracellular microorganisms which depend on the host cellular machinery for replication</p> Signup and view all the answers

<p>There is no standardized in vitro cellular systems and in vivo animal models for studying viruses</p> Signup and view all the answers